JP2015513557A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015513557A5 JP2015513557A5 JP2014561064A JP2014561064A JP2015513557A5 JP 2015513557 A5 JP2015513557 A5 JP 2015513557A5 JP 2014561064 A JP2014561064 A JP 2014561064A JP 2014561064 A JP2014561064 A JP 2014561064A JP 2015513557 A5 JP2015513557 A5 JP 2015513557A5
- Authority
- JP
- Japan
- Prior art keywords
- agent according
- therapeutic agent
- pain
- peripheral neuropathy
- neuropathic pain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 claims 4
- 229940124597 therapeutic agent Drugs 0.000 claims 4
- 208000002193 Pain Diseases 0.000 claims 2
- 208000004296 neuralgia Diseases 0.000 claims 2
- 208000021722 neuropathic pain Diseases 0.000 claims 2
- 208000033808 peripheral neuropathy Diseases 0.000 claims 2
- 208000032131 Diabetic Neuropathies Diseases 0.000 claims 1
- 208000001640 Fibromyalgia Diseases 0.000 claims 1
- 108091000080 Phosphotransferase Proteins 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- 102000020233 phosphotransferase Human genes 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261608849P | 2012-03-09 | 2012-03-09 | |
| US61/608,849 | 2012-03-09 | ||
| PCT/US2013/029258 WO2013134336A2 (en) | 2012-03-09 | 2013-03-06 | Inhibition of adaptor associated kinase 1 for the treatment of pain |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015513557A JP2015513557A (ja) | 2015-05-14 |
| JP2015513557A5 true JP2015513557A5 (OSRAM) | 2016-04-21 |
Family
ID=47884616
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014561064A Pending JP2015513557A (ja) | 2012-03-09 | 2013-03-06 | 疼痛の治療に対するアダプター関連キナーゼ１の阻害 |
Country Status (14)
| Country | Link |
|---|---|
| US (4) | US20140080834A1 (OSRAM) |
| EP (2) | EP2822555B1 (OSRAM) |
| JP (1) | JP2015513557A (OSRAM) |
| CN (1) | CN104220071A (OSRAM) |
| AU (1) | AU2013230066A1 (OSRAM) |
| CA (1) | CA2866145A1 (OSRAM) |
| DK (1) | DK2822555T3 (OSRAM) |
| ES (1) | ES2657061T3 (OSRAM) |
| HK (1) | HK1199814A1 (OSRAM) |
| HU (1) | HUE036040T2 (OSRAM) |
| NO (1) | NO2935475T3 (OSRAM) |
| PL (1) | PL2822555T3 (OSRAM) |
| PT (1) | PT2822555T (OSRAM) |
| WO (1) | WO2013134336A2 (OSRAM) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE038786T2 (hu) * | 2012-03-09 | 2018-11-28 | Lexicon Pharmaceuticals Inc | Pirazolo[1,5-a]pirimidin-alapú vegyületek, ezeket tartalmazó kompozíciók és eljárások alkalmazásukra |
| US8969565B2 (en) * | 2012-03-09 | 2015-03-03 | Lexicon Pharmaceuticals, Inc. | Imidazo[1,2-b]pyridazine-based compounds, compositions comprising them, and methods of their use |
| US8901305B2 (en) | 2012-07-31 | 2014-12-02 | Bristol-Myers Squibb Company | Aryl lactam kinase inhibitors |
| JP2016509066A (ja) | 2013-02-22 | 2016-03-24 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | アダプター関連キナーゼ１（ａａｋ１）の阻害剤としての５ｈ−クロメノ［３，４−ｃ］ピリジン |
| WO2014175370A1 (ja) * | 2013-04-25 | 2014-10-30 | 塩野義製薬株式会社 | ピロリジン誘導体およびそれらを含有する医薬組成物 |
| CN105492444B (zh) * | 2013-07-02 | 2018-09-07 | 百时美施贵宝公司 | 作为rock抑制剂的三环吡啶-甲酰胺衍生物 |
| EP3019475A1 (en) | 2013-07-08 | 2016-05-18 | Bristol-Myers Squibb Company | Aryl amide kinase inhibitors |
| TW201542550A (zh) * | 2013-09-06 | 2015-11-16 | Lexicon Pharmaceuticals Inc | 吡唑并［１，５－ａ］嘧啶基化合物、包含彼之組合物以及使用彼之方法 |
| AR097543A1 (es) * | 2013-09-06 | 2016-03-23 | Lexicon Pharmaceuticals Inc | COMPUESTOS BASADOS EN IMIDAZO[1,2-b]PIRIDAZINA, COMPOSICIONES QUE LOS COMPRENDEN Y SUS MÉTODOS DE USO |
| CA2941192A1 (en) * | 2013-09-11 | 2015-03-19 | Bristol-Myers Squibb Company | Aryl ether-base kinase inhibitors |
| WO2015054358A1 (en) * | 2013-10-11 | 2015-04-16 | Bristol-Myers Squibb Company | Pyrrolotriazine kinase inhibitors |
| US9932320B2 (en) * | 2014-01-31 | 2018-04-03 | Bristol-Myers Squibb Company | Quinoline-based kinase inhibitors |
| TW201620911A (zh) * | 2014-03-17 | 2016-06-16 | 雷西肯製藥股份有限公司 | 銜接子關聯激酶１之抑制劑、包含其之組成物、及其使用方法 |
| RS58062B1 (sr) | 2014-04-02 | 2019-02-28 | Bristol Myers Squibb Co | Biaril inhibitori kinaze |
| WO2016022312A1 (en) * | 2014-08-05 | 2016-02-11 | Bristol-Myers Squibb Company | Heterocyclic kinase inhibitors |
| SMT202400187T1 (it) | 2014-11-06 | 2024-07-09 | Bial R&D Investments S A | Pirazolo(1,5-a)pirimidine sostituite e loro utilizzo nel trattamento di disturbi medici |
| ES2740224T3 (es) | 2015-04-10 | 2020-02-05 | Bristol Myers Squibb Co | 6H-isocromeno[3,4-c]piridinas y benzo[c][1,7]naftiridin-6-(5H)-onas como inhibidores de la cinasa asociada a adaptador 1 (AAK1) |
| CN112142655A (zh) | 2015-10-01 | 2020-12-29 | 百时美施贵宝公司 | 联芳基激酶抑制剂 |
| CN108290843B (zh) | 2015-10-01 | 2021-08-24 | 百时美施贵宝公司 | 联芳基激酶抑制剂 |
| AU2017246455B2 (en) | 2016-04-06 | 2021-09-30 | Bial - R&D Investments, S.A. | Pyrazolo[1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders |
| US10787454B2 (en) | 2016-04-06 | 2020-09-29 | BIAL—BioTech Investments, Inc. | Imidazo[1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders |
| BR112018072552A8 (pt) * | 2016-05-05 | 2023-03-14 | Lysosomal Therapeutics Inc | Compostos de imidazo [1,2-b]piridazinas e imidazo [1,5-b] piridazinas substituídas, composição farmacêutica que os compreende e seu uso no tratamento de distúrbios médicos |
| WO2018013430A2 (en) | 2016-07-12 | 2018-01-18 | Arisan Therapeutics Inc. | Heterocyclic compounds for the treatment of arenavirus infection |
| US12419865B2 (en) | 2018-12-06 | 2025-09-23 | Arisan Therapeutics Inc. | Compounds for the treatment of arenavirus infection |
| KR102590438B1 (ko) * | 2020-10-16 | 2023-10-18 | 김홍렬 | Pmca 억제제를 포함하는 코로나바이러스 감염 또는 감염 질환의 예방 또는 소독용 조성물 |
| KR102590444B1 (ko) * | 2020-10-16 | 2023-10-18 | 김홍렬 | Pmca 억제제를 포함하는 코로나바이러스 감염 또는 감염 질환의 치료용 조성물 |
| WO2023196584A2 (en) * | 2022-04-08 | 2023-10-12 | New York University | Endocytosis inhibitors and their use for pain treatment |
| WO2025225608A1 (en) * | 2024-04-23 | 2025-10-30 | Otsuka Pharmaceutical Co., Ltd. | Tetrahydropyrazolopyridine derivative |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5464764A (en) | 1989-08-22 | 1995-11-07 | University Of Utah Research Foundation | Positive-negative selection methods and vectors |
| AU2515992A (en) | 1991-08-20 | 1993-03-16 | Genpharm International, Inc. | Gene targeting in animal cells using isogenic dna constructs |
| WO2007025090A2 (en) * | 2005-08-25 | 2007-03-01 | Kalypsys, Inc. | Heterobicyclic and - tricyclic inhibitors of mapk/erk kinase |
| CN101522682A (zh) * | 2006-10-30 | 2009-09-02 | 诺瓦提斯公司 | 作为抗炎剂的杂环化合物 |
| EP2300469B1 (en) * | 2008-05-13 | 2015-06-24 | Novartis AG | Fused nitrogen containing heterocycles and compositions thereof as kinase inhibitors |
| WO2010028005A1 (en) * | 2008-09-04 | 2010-03-11 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules |
-
2013
- 2013-03-06 PL PL13709722T patent/PL2822555T3/pl unknown
- 2013-03-06 EP EP13709722.6A patent/EP2822555B1/en active Active
- 2013-03-06 DK DK13709722.6T patent/DK2822555T3/en active
- 2013-03-06 HU HUE13709722A patent/HUE036040T2/hu unknown
- 2013-03-06 CN CN201380012478.XA patent/CN104220071A/zh active Pending
- 2013-03-06 CA CA2866145A patent/CA2866145A1/en not_active Abandoned
- 2013-03-06 US US13/786,575 patent/US20140080834A1/en not_active Abandoned
- 2013-03-06 EP EP17175353.6A patent/EP3235499A3/en not_active Withdrawn
- 2013-03-06 AU AU2013230066A patent/AU2013230066A1/en not_active Abandoned
- 2013-03-06 JP JP2014561064A patent/JP2015513557A/ja active Pending
- 2013-03-06 WO PCT/US2013/029258 patent/WO2013134336A2/en not_active Ceased
- 2013-03-06 PT PT137097226T patent/PT2822555T/pt unknown
- 2013-03-06 ES ES13709722.6T patent/ES2657061T3/es active Active
- 2013-03-06 HK HK15100206.3A patent/HK1199814A1/xx unknown
- 2013-12-11 NO NO13811839A patent/NO2935475T3/no unknown
-
2014
- 2014-08-07 US US14/453,666 patent/US20150164899A1/en not_active Abandoned
-
2016
- 2016-02-26 US US15/054,741 patent/US20160206619A1/en not_active Abandoned
-
2018
- 2018-04-30 US US15/966,274 patent/US20190134037A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015513557A5 (OSRAM) | ||
| JP2015503422A5 (OSRAM) | ||
| JP2017506627A5 (OSRAM) | ||
| JP2016028092A5 (OSRAM) | ||
| JP2016065085A5 (OSRAM) | ||
| JP2015528502A5 (OSRAM) | ||
| CN109843873A (zh) | 炔代杂环化合物、其制备方法及其在医药学上的应用 | |
| JP2014530840A5 (OSRAM) | ||
| EP2953624A4 (en) | METHOD FOR THE TREATMENT OF MICROBIAL INFECTIONS, INCLUDING MASTITIS | |
| JP2016139345A5 (OSRAM) | ||
| EP3307738A4 (en) | ARYL-DIHYDRO-2H-BENZO [B] [1,4] OXAZINE-SULPHONAMIDE AND RELATED COMPOUNDS FOR USE AS AGENTS OF RORY AND FOR THE TREATMENT OF DISEASES | |
| WO2015066302A3 (en) | Compositions, methods of use, and methods of treatment | |
| EP3292119A4 (en) | DIHYDRO-2H-BENZO[b][1,4]OXAZINE SULFONAMIDE AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORy AND THE TREATMENT OF DISEASE | |
| JP2013231052A5 (OSRAM) | ||
| JP2015016294A5 (OSRAM) | ||
| JP2017531686A5 (OSRAM) | ||
| EA201790687A1 (ru) | Хинолинкарбоксамиды для применения в лечении множественной миеломы | |
| EA201692518A2 (ru) | Способы улучшения производительности миокарда у пациентов после операции фонтена с применением композиций уденафила | |
| CN109563051A (zh) | 作为pde4抑制剂的并环类化合物 | |
| BR112014017493A8 (pt) | usos terapêuticos | |
| JP2015005289A5 (OSRAM) | ||
| WO2014180882A3 (en) | Treatment of brain metastasis from cancer | |
| ES2525079A1 (es) | Actividad antiparasitaria de escuaramidas | |
| IL260009B (en) | Novel bicyclic-compounds for use as a medicament, in particular for treatment of parkinson's disease | |
| LT3148588T (lt) | N,n-bis-2-merkaptoetilizoftalamidas, skirtas parkinsono ligos gydymui |